Search results
Results From The WOW.Com Content Network
Global Drug Facility GDF Drugs distributed by doctors The Stop TB Partnership’s Global Drug Facility (GDF) [ 9 ] has changed the landscape of TB care by working closely with countries, suppliers, donors, and other stakeholders to vastly increase global access to the latest quality-assured, affordable TB treatments and diagnostics for people ...
For example, Pakistan uses prices from Bangladesh and India, while Iran uses prices from Greece, Spain, Turkey and the drug country of origin. Drug price data from LMICs can be lacking, and in such situations, international medicine prices can be obtained from the International Medical Products Price Guide. Some countries use ERP for all drug ...
drug screening chemicals list of suppliers and catalog numbers "eMolecules". 8,000,000 [5] ENCS Japanese Existing and New Chemical Substances Inventory: regulated chemicals "ENCS (in Japanese)". Evaluated Kinetic Data IUPAC: rate constants curated "Evaluated Kinetic Data". FDA SRS Food and Drug Administration Substance Registration System
The overall goal of the project is to narrow the huge diagnostic gap in multi-drug-resistant tuberculosis (MDR-TB) control by expanding and accelerating access to new and rapid diagnostic technologies within appropriate laboratory services, accompanied by the necessary technology transfer, and ensuring these new technologies are properly ...
The WHODrug Dictionary is an international classification of medicines created by the WHO Programme for International Drug Monitoring and managed by the Uppsala Monitoring Centre. [ 1 ] It is used by pharmaceutical companies , clinical trial organizations and drug regulatory authorities for identifying drug names in spontaneous ADR reporting ...
Many argue that generic brand production in developing countries increases competition and therefore is essential to bridge the global drug gap. [ 11 ] [ 9 ] As argued by various sources, the push for more measures such as market and data exclusivity, hinders low-income countries' ability to manufacture and produce generic drugs. [ 6 ]
The Global Fund to Fight AIDS, Tuberculosis and Malaria was invited to host the AMFm and, in 2008, the Global Fund Board approved the implementation plan and policy framework for a limited Phase 1 of the AMFm: the launch of the AMFm would be phased, beginning with a limited number of countries (approximately 290 million ACT treatments to be ...
Global Medical Device Nomenclature (GMDN) is a system of internationally agreed generic descriptors used to identify all medical device products. This nomenclature is a naming system for products which include those used for the diagnosis, prevention, monitoring, treatment or alleviation of disease or injury in humans.